Canadian Pharmaceutical Sales ManagementCutting Edge InformationNovember 1, 2007 151 Pages - SKU: CIGQ1627679 |
|
EMR 2012: The Market for Electronic Medical Records
3/13/2012 | published by: Kalorama Information
This report, EMR 2012 is a look at the market and trends impacting electronic medical record software
|
more...
|
$3,500.00
|
|
Out-of-Pocket Healthcare 2012
4/3/2012 | published by: Kalorama Information
Despite numerous attempts to reign in costs of healthcare, consumers are increasingly paying for healthcare products and services from their own monies. The costs of health care products and services continue
|
more...
|
$995.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors
|
more...
|
$3,995.00
|
|
China Healthcare Market Forecast to 2015
5/1/2012 | published by: RNCOS
With the advancement of infrastructure, Chinese Healthcare Industry is entering into a new era of development. A large population-base along with increasing aging population, and continuously growing prevalence of lifestyle diseases are further supporting the
|
more...
|
$1,000.00
|
|
Understanding India's Regional Health Markets
4/23/2012 | published by: Espicom Healthcare Intelligence
Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data on this fast growing economy.
|
more...
|
$690.00
|
|
Chinese Markets for Hepatitis Drugs
4/1/2012 | published by: Asia Market Information & Development Company
China's demand for hepatitis drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
more...
|
$4,000.00
|
|
Pharmaceuticals – Australia – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
Pharmaceuticals in Australia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription and OTC pharmaceuticals. It excludes sales to institutions such as
|
more...
|
$600.00
|
|
Pharmaceuticals – South Korea – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
Pharmaceuticals in South Korea by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription and OTC pharmaceuticals. It excludes sales to institutions such
|
more...
|
$600.00
|
|
China Pharmaceutical Industry Research and Forecast to 2016
3/1/2012 | published by: AM Mindpower Solutions
EXECUTIVE SUMMARY The present report on “China Pharmaceutical Industry Research and Forecast to 2016” analyzes in detail the pharmaceutical industry environment with market sizing in terms of patented drugs, generic drugs, OTC drug and even sub-segments
|
more...
|
$700.00
|
|
Approval of Kalydeco Brings New Hope for CF Patients with G551D Mutation
2/29/2012 | published by: GlobalData
Approval of Kalydeco Brings New Hope for CF Patients with G551D Mutation Summary The report is an essential source of information and analysis on the KALYDECO (ivacaftor, VX-770) for the treatment of Cystic Fibrosis (CF) patients with
|
more...
|
$500.00
|
Related Markets
Prescription Drugs Reports
- Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program
- Chinese Markets for Hepatitis Drugs
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
